OCUL

Ocular Therapeutix, Inc. Healthcare - Biotechnology Investor Relations →

NO
33.7% ABOVE
↓ Approaching Was 33.9% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $6.85
14-Week RSI 38

Ocular Therapeutix, Inc. (OCUL) closed at $9.16 as of 2026-02-02, trading 33.7% above its 200-week moving average of $6.85. The stock is currently moving closer to the line, down from 33.9% last week. The 14-week RSI sits at 38, indicating neutral momentum.

Over the past 554 weeks of data, OCUL has crossed below its 200-week moving average 5 times. On average, these episodes lasted 77 weeks. The average one-year return after crossing below was -19.7%, suggesting these dips have not historically been reliable buying opportunities for this stock.

With a market cap of $1994 million, OCUL is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -54.9%. The stock trades at 3.0x book value.

Share count has increased 179.7% over three years, indicating dilution.

Over the past 10.8 years, a hypothetical investment of $100 in OCUL would have grown to $46, compared to $402 for the S&P 500. OCUL has returned -7.1% annualized vs 13.8% for the index, underperforming the broader market over this period.

Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.

Growth of $100: OCUL vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After OCUL Crosses Below the Line?

Across 5 historical episodes, buying OCUL when it crossed below its 200-week moving average produced an average return of -18.0% after 12 months (median -47.0%), compared to +5.8% for the S&P 500 over the same periods. 40% of those episodes were profitable after one year. After 24 months, the average return was -55.7% vs +15.7% for the index.

Each line shows $100 invested at the moment OCUL crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

OCUL has crossed below its 200-week MA 5 times with an average 1-year return of +-19.7% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Jun 2015Jul 2015211.3%-75.7%-54.5%
Aug 2015May 202024873.9%-69.5%-56.8%
Oct 2021Feb 202412273.4%-46.7%+32.6%
Apr 2024Jul 20241240.2%+40.0%+75.5%
Jul 2024Aug 202410.5%+53.2%+17.7%
Average77+-19.7%

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of Friday close, 2026-02-02